Marianne P. Allen

Array ( [id] => 8796643 [patent_doc_number] => 08435510 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-05-07 [patent_title] => 'Platelet derived growth factor receptor supports cytomegalovirus infectivity' [patent_app_type] => utility [patent_app_number] => 12/672491 [patent_app_country] => US [patent_app_date] => 2008-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 21 [patent_no_of_words] => 15095 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12672491 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5972494 [patent_doc_number] => 20110152187 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-23 [patent_title] => 'INSULIN-LIKE GROWTH FACTOR FUSION PROTEINS' [patent_app_type] => utility [patent_app_number] => 12/672000 [patent_app_country] => US [patent_app_date] => 2008-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 6621 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20110152187.pdf [firstpage_image] =>[orig_patent_app_number] => 12672000 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5290928 [patent_doc_number] => 20090023658 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-22 [patent_title] => 'Neovascularization Inhibitors Derived From HGF and Methods Involving the Same' [patent_app_type] => utility [patent_app_number] => 12/186261 [patent_app_country] => US [patent_app_date] => 2008-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 9274 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0023/20090023658.pdf [firstpage_image] =>[orig_patent_app_number] => 12186261 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5545391 [patent_doc_number] => 20090155268 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-18 [patent_title] => 'Growth Factor Binding Constructs Materials and Methods' [patent_app_type] => utility [patent_app_number] => 12/180990 [patent_app_country] => US [patent_app_date] => 2008-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 36266 [patent_no_of_claims] => 62 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0155/20090155268.pdf [firstpage_image] =>[orig_patent_app_number] => 12180990 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5310241 [patent_doc_number] => 20090017522 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-15 [patent_title] => 'Polynucleotides Encoding Promyostatin Polypeptides' [patent_app_type] => utility [patent_app_number] => 12/166035 [patent_app_country] => US [patent_app_date] => 2008-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 47627 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0017/20090017522.pdf [firstpage_image] =>[orig_patent_app_number] => 12166035 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4710593 [patent_doc_number] => 20080299119 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-04 [patent_title] => 'POLYPEPTIDES HOMOLOGOUS TO VEGF AND BMP1' [patent_app_type] => utility [patent_app_number] => 12/147363 [patent_app_country] => US [patent_app_date] => 2008-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 38448 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0299/20080299119.pdf [firstpage_image] =>[orig_patent_app_number] => 12147363 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4520973 [patent_doc_number] => 07951368 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-05-31 [patent_title] => 'Compositions of specific binding agents to hepatocyte growth factor' [patent_app_type] => utility [patent_app_number] => 12/146431 [patent_app_country] => US [patent_app_date] => 2008-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 32610 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/951/07951368.pdf [firstpage_image] =>[orig_patent_app_number] => 12146431 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8385679 [patent_doc_number] => 08263072 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-09-11 [patent_title] => 'ADAMTS4 as a blood biomarker and therapeutic target for chronic renal failure' [patent_app_type] => utility [patent_app_number] => 12/665270 [patent_app_country] => US [patent_app_date] => 2008-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 15096 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12665270 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4853431 [patent_doc_number] => 20080319174 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-25 [patent_title] => 'CHIMERA HUMANIZED VASCULAR ENDOTHELIAL GROWTH FACTOR' [patent_app_type] => utility [patent_app_number] => 12/142601 [patent_app_country] => US [patent_app_date] => 2008-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 9300 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0319/20080319174.pdf [firstpage_image] =>[orig_patent_app_number] => 12142601 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4853435 [patent_doc_number] => 20080319178 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-25 [patent_title] => 'CHIMERA HUMANIZED VASCULAR ENDOTHELIAL GROWTH FACTOR' [patent_app_type] => utility [patent_app_number] => 12/142613 [patent_app_country] => US [patent_app_date] => 2008-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 9297 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0319/20080319178.pdf [firstpage_image] =>[orig_patent_app_number] => 12142613 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9139798 [patent_doc_number] => 08580254 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-11-12 [patent_title] => 'Anti-IGF antibodies' [patent_app_type] => utility [patent_app_number] => 12/665373 [patent_app_country] => US [patent_app_date] => 2008-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 14734 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12665373 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5296065 [patent_doc_number] => 20090010991 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-08 [patent_title] => 'Nasal Passage Stent' [patent_app_type] => utility [patent_app_number] => 12/131262 [patent_app_country] => US [patent_app_date] => 2008-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 690 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0010/20090010991.pdf [firstpage_image] =>[orig_patent_app_number] => 12131262 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6443568 [patent_doc_number] => 20100144592 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-10 [patent_title] => 'Stable Non-Aqueous Pharmaceutical Compositions' [patent_app_type] => utility [patent_app_number] => 12/601884 [patent_app_country] => US [patent_app_date] => 2008-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 18496 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0144/20100144592.pdf [firstpage_image] =>[orig_patent_app_number] => 12601884 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5284456 [patent_doc_number] => 20090098131 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-16 [patent_title] => 'Compositions and methods for the treatment of immune related diseases' [patent_app_type] => utility [patent_app_number] => 12/153928 [patent_app_country] => US [patent_app_date] => 2008-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2825 [patent_figures_cnt] => 2825 [patent_no_of_words] => 61274 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12153928 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8533370 [patent_doc_number] => 08309525 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-11-13 [patent_title] => 'Treatment of type 2 diabetes, metabolic syndrome, myocardial injury and neurodegeneration with humanin and analogs thereof' [patent_app_type] => utility [patent_app_number] => 12/451524 [patent_app_country] => US [patent_app_date] => 2008-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 33 [patent_no_of_words] => 24295 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12451524 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4840330 [patent_doc_number] => 20080280816 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-13 [patent_title] => 'METHODS AND PHARMACEUTICAL COMPOSITIONS FOR HEALING WOUNDS' [patent_app_type] => utility [patent_app_number] => 12/120954 [patent_app_country] => US [patent_app_date] => 2008-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 23490 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0280/20080280816.pdf [firstpage_image] =>[orig_patent_app_number] => 12120954 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5452189 [patent_doc_number] => 20090068226 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-12 [patent_title] => 'Bacterial superantigen vaccines' [patent_app_type] => utility [patent_app_number] => 12/151497 [patent_app_country] => US [patent_app_date] => 2008-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 17736 [patent_no_of_claims] => 66 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0068/20090068226.pdf [firstpage_image] =>[orig_patent_app_number] => 12151497 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4959696 [patent_doc_number] => 20080274121 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-06 [patent_title] => 'Inhibition of Angiogenesis by Mithramycin' [patent_app_type] => utility [patent_app_number] => 12/112610 [patent_app_country] => US [patent_app_date] => 2008-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 17385 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0274/20080274121.pdf [firstpage_image] =>[orig_patent_app_number] => 12112610 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6353348 [patent_doc_number] => 20100086554 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-08 [patent_title] => 'METHODS FOR ADMINISTERING ANTI-IL-5 ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 12/598319 [patent_app_country] => US [patent_app_date] => 2008-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8370 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0086/20100086554.pdf [firstpage_image] =>[orig_patent_app_number] => 12598319 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6545671 [patent_doc_number] => 20100222265 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-02 [patent_title] => 'HEPARIN BINDING EPIDERMAL GROWTH FACTOR (HB-EGF) FOR USE IN METHODS OF TREATING AND PREVENTING INTESTINAL INJURY RELATED TO HEMORRHAGIC SHOCK AND RESUSCITATION' [patent_app_type] => utility [patent_app_number] => 12/598082 [patent_app_country] => US [patent_app_date] => 2008-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8412 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0222/20100222265.pdf [firstpage_image] =>[orig_patent_app_number] => 12598082 [rel_patent_id] =>[rel_patent_doc_number] =>)